Form 4 for CI Cigna
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001225208-24-003709 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-05 | 2024-03-01 | CI | Evanko Brian C | See Remarks | F - Tax | $333.36 | -5,435 | 43.8K | -11% | -$1.81M |
| 2024-03-05 | 2024-03-01 | CI | Evanko Brian C | See Remarks | A - Grant | $0.00 | +8,329 | 45.4K | +22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $.01 Par Value | 2024-03-01 | F | D | 3,860 | $333.36 | 39,923 | D | — | — | (F3) Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. |
| 2 | Common | Common Stock, $.01 Par Value | 2024-03-01 | A | A | 8,329 | $0.00 | 45,358 | D | — | — | (F1) The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2021-2023 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. |
| 3 | Common | Common Stock, $.01 Par Value | 2024-03-01 | F | D | 1,575 | $333.36 | 43,783 | D | — | — | (F2) Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. |